Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Exp Dermatol. 2019 Dec;28(12):1476-1481. doi: 10.1111/exd.14007. Epub 2019 Aug 13.
Patients with chronic pruritus are in desperate need of novel treatment options, as current therapeutic possibilities are often not effective, have a poor level of evidence and are mostly off-label. In recent years, much effort has been put into the identification of potential targets for the treatment of chronic pruritus. More importantly, a number of promising new drugs that are aimed at treating pruritus in different conditions are currently in advanced stages of clinical trials. Here, current pharmacological developments leading to potential new drugs for the treatment of chronic pruritus within various conditions are summarized. Hopefully, these new approaches will result in effective and safe therapies for our patients with chronic pruritus associated with dermatological or non-dermatological diseases in the near future.
患有慢性瘙痒的患者迫切需要新的治疗选择,因为目前的治疗方法往往效果不佳,证据水平低,而且大多是非适应证用药。近年来,人们在识别治疗慢性瘙痒的潜在靶点方面付出了巨大努力。更重要的是,目前有许多针对不同疾病瘙痒治疗的有前途的新药已处于临床试验的后期阶段。在这里,总结了导致各种疾病慢性瘙痒潜在新药的当前药理学进展。希望这些新方法将在不久的将来为患有与皮肤病或非皮肤病相关的慢性瘙痒的患者带来有效且安全的治疗方法。